Androgenetic Alopecia as an Early Marker of Benign Prostatic Hyperplasia

August 2011 in “ Journal of The American Academy of Dermatology ”

Salvador Arias-Santiago, Miguel Angel Arrabal-Polo, Agustín Buendía-Eisman, Miguel Arrabal-Martin, María Teresa Gutiérrez-Salmerón, María Sierra Girón-Prieto, Antonio Jiménez-Pacheco, Jaime Eduardo Calonje, Ramón Naranjo-Sintes, Armando Zuluaga-Gomez, Salvio Serrano Ortega

androgenetic alopecia benign prostatic hyperplasia AGA prostate volume urinary flow International Prostate Symptom Score IPSS BPH

Studysummary This study found that men with early-onset androgenetic alopecia had significantly larger prostate volumes and lower urinary flow rates compared to healthy controls, suggesting a possible link between AGA and prostate-related urinary symptoms. Our plain-language summary of this paper — not a Tressless recommendation.

This study found that early-onset androgenetic alopecia (AGA) may be an early marker of urinary/prostatic symptomatology. Patients with AGA had a larger prostate, lower urinary flow value, and higher International Prostate Symptom Score (IPSS) in comparison with individuals without AGA. AGA was found to be an independent risk factor for a prostate volume greater than 30 mL, urinary flow less than 15 mL/s, and benign prostatic hyperplasia (BPH). The study suggests that dermatologists and primary care physicians should monitor patients with early-onset AGA for the development of urinary symptoms to permit an earlier diagnosis.

View this study on jaad.org →

Discuss this study in the Community →

Research cited in this study

21 / 21 results

research Sex Hormone–Binding Globulin and Risk of Hyperglycemia in Patients With Androgenetic Alopecia

36 citations , April 2011 in “Journal of The American Academy of Dermatology”

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

research Lipid Levels in Women with Androgenetic Alopecia

15 citations , October 2010 in “International Journal of Dermatology”

Women with AGA have higher lipid levels, increasing heart disease risk.

research Androgenetic Alopecia and Cardiovascular Risk Factors in Men and Women: A Comparative Study

110 citations , July 2010 in “Journal of The American Academy of Dermatology”

Hair loss linked to higher heart disease risk in both men and women.

research Male Androgenetic Alopecia and Cardiovascular Risk Factors: A Case-Control Study

23 citations , March 2010 in “Actas Dermo-Sifiliográficas”

In this study, early-onset androgenetic alopecia in men was associated with a higher prevalence of metabolic syndrome and carotid atherosclerosis compared to controls, suggesting cardiovascular screening might be beneficial for this group.

research Does D Matter? The Role of Vitamin D in Hair Disorders and Hair Follicle Cycling

98 citations , February 2010 in “Dermatology Online Journal”

This article outlines the potential for upregulating the vitamin D receptor in treating hair disorders, emphasizing the need for further studies to evaluate vitamin D's role in the hair cycle.

research A Comparative Study of Dyslipidemia in Men and Women with Androgenic Alopecia

37 citations , January 2010 in “Acta dermato-venereologica”

This study found that both men and women with androgenic alopecia had significantly higher triglycerides, total cholesterol, and LDL-C and lower HDL-C levels than controls, suggesting increased dyslipidemia prevalence.

research Hypertension and Aldosterone Levels in Women with Early-Onset Androgenetic Alopecia

45 citations , November 2009 in “British Journal of Dermatology”

This study found that women with early-onset androgenetic alopecia had higher aldosterone levels and blood pressure, suggesting a possible link to the increased prevalence of hypertension in this group.

research Elevated Aldosterone Levels in Patients with Androgenetic Alopecia

30 citations , June 2009 in “British Journal of Dermatology”

This study suggests that elevated aldosterone may contribute to androgenic alopecia development and its association with higher hypertension prevalence, emphasizing the importance of blood pressure screening in affected patients.

research Does Degree of Baldness Influence Vitamin D Status?

19 citations , December 2008 in “Medical Journal of Australia”

This study found no significant association between the degree of male-pattern baldness and serum 25-hydroxyvitamin D levels in healthy middle-aged and older men.

research Baldness, Benign Prostate Hyperplasia, Prostate Cancer, and Androgen Levels

30 citations , January 2008 in “The Aging Male”

This study found no difference in male pattern baldness between patients with benign prostate hyperplasia and prostate cancer, and no correlation with serum androgen levels.

The Importance of Dual 5α-Reductase Inhibition in the Treatment of Male Pattern Hair Loss: Results of a Randomized Placebo-Controlled Study of Dutasteride Versus Finasteride

research The Importance of Dual 5α-Reductase Inhibition in the Treatment of Male Pattern Hair Loss: Results of a Randomized Placebo-Controlled Study of Dutasteride Versus Finasteride

215 citations , November 2006 in “Journal of The American Academy of Dermatology”

This study found that dutasteride increased scalp hair growth in men with male pattern hair loss, particularly at a 2.5 mg dose, and was more effective than finasteride over 24 weeks.

research Protection Against Chemotherapy-Induced Alopecia

97 citations , September 2006 in “Pharmaceutical Research”

This review discusses advances in protecting against chemotherapy-induced alopecia and reports no new clinical results; calcitriol and cyclosporine A emerged as promising agents in animal models with broader efficacy across multiple chemotherapy drugs.

The Preventive Effect of Vitamin D3 on Radiation-Induced Hair Toxicity in a Rat Model

research The Effect of Finasteride, a 5 Alpha-Reductase Inhibitor, on Scalp Skin Testosterone and Dihydrotestosterone Concentrations in Patients With Male Pattern Baldness

61 citations , September 1994 in “The Journal of Clinical Endocrinology and Metabolism”

research The Effect of Finasteride in Men with Benign Prostatic Hyperplasia

1040 citations , October 1992 in “The New England Journal of Medicine”

In this study, 5 mg of finasteride per day significantly improved urinary symptoms and reduced prostate volume in men with benign prostatic hyperplasia, but increased the risk of sexual dysfunction.